IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bionexus Gene LAB Corp (BGLC)

CUSIP: 090628306 | NYSE | Basic Materials · Specialty Chemicals | Micro Cap | 6 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DTan Lee Su-Leng338,70911.5%New 5%+ stakeAug 13, 2026No 13F filer matched
13GFidelion Diagnostics Pte. Ltd.392,32913.4%New 5%+ stakeNov 28, 2025

Institutional Holders — Q3 2026

UBS Group AG306
0.0% of portfolio›$373
Caitong International Asset Management Co., Ltd137
0.0% of portfolio›$167
StyleTurnoverLocationFiled
UBS Group AG
306$3730.0%CoreMediumZurich, Switzerland2026-11-10
Caitong International Asset Management Co., Ltd
137$1670.0%GrowthVery HighHong Kong, South Korea2026-10-29
No 13F filer matched
13DTan Lee Su-Leng338,709
11.5% of class · Aug 13, 2026New 5%+ stake
No 13F filer matched
13GFidelion Diagnostics Pte. Ltd.392,329
13.4% of class · Nov 28, 2025New 5%+ stake
No 13F filer matched